Fig. 2

Clinical and functional measures of motor function in all subjects with SCI during the four testing sessions of the subacute phase, and subcategorised into individuals with and without SCI spasticity syndrome. a. Total muscle (Quadriceps, Hamstring, Tibialis Anterior and Triceps Surae) strength score (0–20) [29]. b. Maximum voluntary dorsiflexion torque. Dotted line represents the median level of torque recorded from the noninjured control group. c. Gait function scale (WISCI II) (0–20) [30]. *: p < 0.05 with respect to session 1. Data are presented as median values with 25th and 75th percentiles